The company is developing a revolutionary medical device to cure brain aneurysms; a life-threatening disease affecting 1 in 50 persons in a strongly growing market valued over $1 billion. In 2017 it won ‘Best Med-Tech Start-Up’ at the Oxford Bio Network awards, 1st place at the BioTrinity ‘Perfect Pitch’ competition and an award at the ‘European Health Catapult’ finals.
Mike has 28 years of growing international businesses in large corporations & start-ups.
Experienced in strategic planning, execution, team building, gaining regulatory approvals & fundraising including winning a prestigious Horizon 2020 SME instrument grant.
Mike mentors budding entrepreneurs, is a panelist at industry conferences and sits on the ‘Misfit’ organization steering committee. He studied Pre-Clinical Medicine, Physiology & Pharmacology at Southampton University and holds an MBA from Henley Business School, UK